Mirum Pharmaceuticals, Inc. MIRM Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Mirum Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Mirum Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mirum Pharmaceuticals, Inc.'s change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mirum Pharmaceuticals, Inc.'s change in other assets?
- Mirum Pharmaceuticals, Inc. (MIRM) reported change in other assets of $6.63M in Q1 2026.
- How has Mirum Pharmaceuticals, Inc.'s change in other assets changed year-over-year?
- Mirum Pharmaceuticals, Inc.'s change in other assets increased by 118.9% year-over-year, from $3.03M to $6.63M.
- What is the long-term trend for Mirum Pharmaceuticals, Inc.'s change in other assets?
- Over 2 years (2021 to 2023), Mirum Pharmaceuticals, Inc.'s change in other assets has grown at a -5.2% compound annual growth rate (CAGR), from $4.01M to $3.6M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.